Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
11 Nov, 2026, 11.00 AM IST
Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's LabsIndian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, c...
09 Nov, 2026, 06.00 AM IST
NMMS scholarship 2026-27 deadline extended: Check new date, eligibility and application processThe Ministry of Education has extended the NMMS scholarship application deadline for the 2026-27 academic year to November 15. Students can...
01 Nov, 2026, 02.47 PM IST
Stocks in news: Infosys, Kotak Mahindra Bank, YES Bank, Raymond, BPCL, Coforge and Senco GoldIndian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...
26 Oct, 2026, 06.00 AM IST
Cipla subsidiary clears USFDA inspection with zero observationsCipla on Friday said a routine US Food and Drug Administration (USFDA) inspection at its wholly owned subsidiary InvaGen Pharmaceuticals' m...
23 Oct, 2026, 12.33 PM IST
Dr Reddy’s Laboratories receives two observations for Andhra Pradesh facilityThe US health regulator completed a Pre-Approval Inspection (PAI) at the company's FTO-11 manufacturing unit from October 5-7, Dr Reddy's L...
09 Oct, 2026, 12.24 AM IST
India's first mineral exchange may be operationalised by next fiscal: OfficialThe government plans to operationalise India’s first mineral exchange by the next financial year, aiming to enable transparent trading and ...
22 Sep, 2026, 03.21 PM IST
Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observationsAlembic Pharmaceuticals has reported that its Vadodara facility passed the recent inspection by the United States Food and Drug Administrat...
11 Sep, 2026, 02.18 PM IST
USFDA issues Form 483 with 11 observations to Raleigh plant of Aurobindo Pharma armAurobindo Pharma Ltd announced that the USFDA issued a Form 483 with 11 observations following an inspection of its Aurolife Pharma LLC's R...
11 Apr, 2025, 05.55 PM IST
Shilpa Medicare shares hit lower circuit after USFDA observations for Telangana unitThe US Food and Drug Administration (USFDA) issued form 483 with 15 observations to the company’s Jadcherla Unit
26 Feb, 2020, 01.23 PM IST
USFDA finds several violations in Aurobindo sterile injections unitFDA investigators have observed violations in sterilisation process to prevent microbial contamination and shortcomings in facility managem...
23 Nov, 2019, 11.11 AM IST
USFDA concludes inspection of Unichem Lab's Roha facilityThe inspection was a post-approval inspection and successfully concluded.
13 Sep, 2019, 03.41 PM IST
USFDA issues 5 observations to Dr Reddy's plant in HyderabadDr.Reddy's Laboratories was issued a Form 483 which notifies the company's management of objectionable conditions, with 5 observations.
12 Jul, 2019, 04.57 PM IST
Aurobindo Pharma drops 5% on USFDA observationsShares of Aurobindo Pharma declined to Rs 605.90.
14 Jun, 2019, 04.02 PM IST
Sun Pharma gets 6 observations by USFDA for its Halol facility"At the conclusion of the inspection, the agency issued a Form 483, with six observations," it added.
07 Sep, 2018, 05.25 PM IST
Received observations from USFDA, responded to all: BioconThe company was responding to reports that the US health regulator has issued observations under Form 483 highlighting issues related to qu...
10 May, 2017, 02.02 PM IST
Lupin gets three observations from USFDA for Goa plantAs per the USFDA, observations are made in Form 483 when investigators feel that practices in the facility are such that products may becom...
28 Apr, 2017, 11.12 PM IST